• Home
  • Technology
    • The platform
    • Artificial Intelligence
    • BioClick
    • Nobel Prize heritage
    • Biosolution phases
    • Scientific papers
    • Patents
  • Pipeline
    • Pipeline overview
    • NCT: Over-the-Counter
    • NCT: Pharma
    • Cannabinoids
    • Santalene
    • Become a partner
  • Investors
    • Stock information
    • News
    • Email signup
    • Investor Relation Contacts
    • Governance
    • SEC Filings
    • Video
  • About
    • Leadership team
    • History
    • Jobs
    • Contact
  • News
    • Latest news
    • Media coverage
    • Investor news
eXoZymes
Home

Technology

The platform Artificial Intelligence BioClick Scientific papers

Pipeline

Pipeline overview NCT: Over-the-Counter NCT: Pharma Cannabinoids Santalene

Investors

Stock information SEC Filings Email signup

About

About eXoZymes Jobs News
  1. Home
  2. eXoZymes

enzymes x AI = exozymes

The eXoZymes video library

Interviews, investor updates and the science behind cell-free biomanufacturing. Watch the platform that turns rare, unscalable chemistry into predictable production.

12 videos

Slack Capital interview: Michael Heltzen, CEO (teaser)
interview
Slack Capital interview: Michael Heltzen, CEO (teaser) May 13, 2025 · 73 views
eXoZymes launches subsidiary, NCTx, to unlock a promising compound for gut and liver health
investors
eXoZymes launches subsidiary, NCTx, to unlock a promising compound for gut and liver health May 06, 2025 · 259 views
AI transforming biotechnology: From form with AlphaFold to function with exozymes
investors
AI transforming biotechnology: From form with AlphaFold to function with exozymes April 28, 2025 · 298 views
GEN Biotechnology: exozymes as the cover story in April 2025 issue
science
GEN Biotechnology: exozymes as the cover story in April 2025 issue April 21, 2025 · 116 views
Bloomberg TV interview with Tyler Korman, co-founder and VP of Research
interview
Bloomberg TV interview with Tyler Korman, co-founder and VP of Research April 15, 2025 · 133 views
BioClick - an enzyme engineering game-changer
science
BioClick - an enzyme engineering game-changer April 10, 2025 · 324 views
eXoZymes 4th quarter and full year 2024 results conference call @ Wednesday April 2, 2025
Webinars
eXoZymes 4th quarter and full year 2024 results conference call @ Wednesday April 2, 2025 April 03, 2025 · 297 views
Introducing our new CCO: Damien Perriman
investors
Introducing our new CCO: Damien Perriman April 02, 2025 · 154 views
Fox Business: Interview with Chief Market Strategist, Lou Basenese
interview
Fox Business: Interview with Chief Market Strategist, Lou Basenese March 17, 2025 · 191 views
Fox Business interview with CEO Michael Heltzen
investors
Fox Business interview with CEO Michael Heltzen March 13, 2025 · 121 views
How eXoZymes started: Interviews with Tyler Korman and Paul Opgenorth
interview
How eXoZymes started: Interviews with Tyler Korman and Paul Opgenorth March 10, 2025 · 72 views
Nasdaq tower: An hour of eXoZymes
General
Nasdaq tower: An hour of eXoZymes February 24, 2025 · 54 views
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

eXoZymes Inc.

750 Royal Oaks Dr, st 106, 
Monrovia 91016, CA, USA

P: (626) 415-1488
E: info@exozymes.com

 

© eXoZymes Inc. [Nasdaq:EXOZ] unshackling enzymes since 2019 (formerly known as Invizyne Technologies)

Videos Webinars Investors SEC Filings Privacy Policy Terms of Use